What is the address of DR. CHAPELLE KAREN - STOMATOLOGIE?

The registered office of DR. CHAPELLE KAREN - STOMATOLOGIE is located at Lindelei 33, 2547 Lint.

Is DR. CHAPELLE KAREN - STOMATOLOGIE still active?

Yes. According to the CBE (29 September 2026) DR. CHAPELLE KAREN - STOMATOLOGIE is active, legal situation “Normale toestand”, started on 12 January 2009.

Is DR. CHAPELLE KAREN - STOMATOLOGIE registered on Peppol?

Yes, DR. CHAPELLE KAREN - STOMATOLOGIE is registered on the Peppol network with ID 0208:0809183304.

What is the enterprise number of DR. CHAPELLE KAREN - STOMATOLOGIE?

The enterprise number of DR. CHAPELLE KAREN - STOMATOLOGIE is BE0809183304.

When was DR. CHAPELLE KAREN - STOMATOLOGIE founded?

DR. CHAPELLE KAREN - STOMATOLOGIE was founded on 12 January 2009.

Who are the directors of DR. CHAPELLE KAREN - STOMATOLOGIE?

According to the 2025 annual accounts, the directors of DR. CHAPELLE KAREN - STOMATOLOGIE are: Karen Chapelle.

Is DR. CHAPELLE KAREN - STOMATOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 January 2009; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. CHAPELLE KAREN - STOMATOLOGIE make in 2025?

DR. CHAPELLE KAREN - STOMATOLOGIE recorded a loss after taxes of € 6,930 in financial year 2025.

What is the revenue of DR. CHAPELLE KAREN - STOMATOLOGIE?

As a small company, DR. CHAPELLE KAREN - STOMATOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 8,356.

DR. CHAPELLE KAREN - STOMATOLOGIE (Private Limited)

Dossier DR. CHAPELLE KAREN - STOMATOLOGIE, printed on 29 September 2026 from databakkes.be/en/0809183304/dr-chapelle-karen-stomatologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. CHAPELLE KAREN - STOMATOLOGIE from Lint, company number BE0809183304, closed financial year 2025 with a result of € -6,930 after tax. For that financial year DR. CHAPELLE KAREN - STOMATOLOGIE recorded a gross margin of € 8,356 and equity of € 693,794. Compared with financial year 2024, the result moved from € 13,076 to € -6,930. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 28, 2026.

What it is worth Healthy

€ 693,794

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -6,930

▼ still € 13,076 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 121,803

▼ 47% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 681,394.

People and assets in 2025

Vehicles and equipment

€ 4,073

▼ 81% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 5

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 1,864

▲ 32% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 127,554 Gross margin 2022: € 127,554 First fiscal year in the series	€ 81,304 Gross margin 2023: € 81,304 ▼ 36% vs 2022 (€ 127,554) Unfavourable step	€ 34,821 Gross margin 2024: € 34,821 ▼ 57% vs 2023 (€ 81,304) Unfavourable step	€ 8,356 Gross margin 2025: € 8,356 ▼ 76% vs 2024 (€ 34,821) Unfavourable step	▼ 76%
Profit after taxes	€ 78,879 Profit after taxes 2022: € 78,879 First fiscal year in the series	€ 46,273 Profit after taxes 2023: € 46,273 ▼ 41% vs 2022 (€ 78,879) Unfavourable step	€ 13,076 Profit after taxes 2024: € 13,076 ▼ 72% vs 2023 (€ 46,273) Unfavourable step	€ -6,930 Profit after taxes 2025: € -6,930 ▼ € 20,006 vs 2024 (€ 13,076) Unfavourable step	▼ € 20,006
Equity	€ 767,022 Equity 2022: € 767,022 First fiscal year in the series	€ 813,295 Equity 2023: € 813,295 ▲ 6% vs 2022 (€ 767,022) Favourable step	€ 700,724 Equity 2024: € 700,724 ▼ 14% vs 2023 (€ 813,295) Unfavourable step	€ 693,794 Equity 2025: € 693,794 ▼ 1% vs 2024 (€ 700,724) Unfavourable step	▼ 1%
Total debts	€ 306,560 Total debts 2022: € 306,560 First fiscal year in the series	€ 171,790 Total debts 2023: € 171,790 ▼ 44% vs 2022 (€ 306,560) Favourable step	€ 289,505 Total debts 2024: € 289,505 ▲ 69% vs 2023 (€ 171,790) Unfavourable step	€ 176,516 Total debts 2025: € 176,516 ▼ 39% vs 2024 (€ 289,505) Favourable step	▼ 39%
Cash	€ 178,009 Cash 2022: € 178,009 First fiscal year in the series	€ 171,946 Cash 2023: € 171,946 ▼ 3% vs 2022 (€ 178,009) Unfavourable step	€ 229,139 Cash 2024: € 229,139 ▲ 33% vs 2023 (€ 171,946) Favourable step	€ 121,803 Cash 2025: € 121,803 ▼ 47% vs 2024 (€ 229,139) Unfavourable step	▼ 47%
Retained profit	€ 754,622 Retained profit 2022: € 754,622 First fiscal year in the series	€ 800,895 Retained profit 2023: € 800,895 ▲ 6% vs 2022 (€ 754,622) Favourable step	€ 688,324 Retained profit 2024: € 688,324 ▼ 14% vs 2023 (€ 800,895) Unfavourable step	€ 681,394 Retained profit 2025: € 681,394 ▼ 1% vs 2024 (€ 688,324) Unfavourable step	▼ 1%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 125,648 Dividend 2024: € 125,648 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 125,648) Unchanged	▼ 100%
Bank debt	€ 14 Bank debt 2022: € 14 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 14) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 5 Bank debt 2025: € 5 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 1,073,583 Balance sheet total 2022: € 1,073,583 First fiscal year in the series	€ 985,085 Balance sheet total 2023: € 985,085 ▼ 8% vs 2022 (€ 1,073,583) Unchanged	€ 990,229 Balance sheet total 2024: € 990,229 ▲ 1% vs 2023 (€ 985,085) Unchanged	€ 870,310 Balance sheet total 2025: € 870,310 ▼ 12% vs 2024 (€ 990,229) Unchanged	▼ 12%

Key figures of DR. CHAPELLE KAREN - STOMATOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to DR. CHAPELLE KAREN - STOMATOLOGIE?

What happened at DR. CHAPELLE KAREN - STOMATOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 28, 2026 New annual accounts for financial year 2025: loss of € 6,930 (▼ € 20,006 vs 2024). Source: NBB ↗
Jan 12, 2009 New establishment in Lint. KBO
Jan 12, 2009 Start of the company according to the CBE. KBO

In short

From € 78,879 profit in 2022 to € 6,930 loss in 2025.

Paid € 52,928 in corporate taxes since 2022.

Best year ever: 2022, with € 78,879 profit.

Paid out € 125,648 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. CHAPELLE KAREN - STOMATOLOGIE? We notify you, reason included.

Follow DR. CHAPELLE KAREN - STOMATOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit